Entrectinib treatment induces a durable response against ARHGEF11::NTRK1 fusion gene-positive spinal cord diffuse pediatric-type high-grade glioma.
Mitsuru MiyachiYohei SugimotoYuya SugitatsuAkimasa TomidaHideki YoshidaKunihiko TsuchiyaDaisuke UmebayashiTakumi YamanakaNaoya HashimotoYukiko Shishido-HaraEiichi KonishiTomoko IeharaPublished in: Pediatric blood & cancer (2023)